Evidence map›Paper›PMID 41485781›Full record

ArticleBMJ open2026

Prevention of postoperative complications with negative pressure wound therapy after complex breast cancer surgery: a study protocol of a randomised controlled trial (TPN-SEIN).

Mathias Neron, Laure Delmond, Sophie Gourgou, Stéphanie Delaine, Patrick Chalbos, Aurore Moussion, Christophe Taoum

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06265558 (Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06265558 narecruitingnot on this map

Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery: a Prospective Randomized Controlled Trial

TypeinterventionalSponsorInstitut du Cancer de Montpellier - Val d'AurelleRan2025 to 2027Enrolled254ConditionsBreast CancerArmsNegative pressure therapy (NPT), Dressing
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mathias NeronDepartment of Surgical Oncology, Montpellier Cancer Institute, Montpellier, France.
Laure DelmondDepartment of Surgical Oncology, Montpellier Cancer Institute, Montpellier, France.
Sophie GourgouUniversity of Montpellier, Montpellier, France.
Stéphanie DelaineUniversity of Montpellier, Montpellier, France.
Patrick ChalbosUniversity of Montpellier, Montpellier, France.
Aurore MoussionUniversity of Montpellier, Montpellier, France.
Christophe TaoumDepartment of Surgical Oncology, Montpellier Cancer Institute, Montpellier, France christophe.taoum@icm.unicancer.fr.ORCID http://orcid.org/0000-0002-7401-331X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundComplex breast surgery, including immediate breast reconstruction and oncoplastic procedures, is increasingly performed to optimise oncologic and aesthetic outcomes. Postoperative wound healing complications remain a major concern, particularly in high-risk patients. Negative pressure wound therapy (NPWT) has been shown to improve wound healing in various surgical fields. However, its effectiveness in oncologic breast surgery remains insufficiently studied. This study aims to evaluate the efficacy of NPWT in reducing wound healing complications in complex breast cancer surgery.

methodsThe TPN-SEIN study is a prospective, randomised, controlled, open-label, multicentre, phase III clinical trial. A total of 254 patients undergoing complex breast cancer surgery will be randomised either to arm 1 (NPWT immediately postoperatively for 7 days) or arm 2 (standard wound care). The primary endpoint is the rate of wound healing complications at day 30, defined as at least one of the following: deep postoperative infection of the prosthetic pocket, wound dehiscence or incomplete healing. Secondary endpoints include surgical site infection at day 90, reoperation rate, hospital readmission rate, time to complete healing, time to adjuvant treatment initiation, quality of life (European Organisation for Research and Treatment of Cancer Core Quality of Life questionnaire and breast cancer-specific quality of life questionnaire (QLQ-C30)), patient satisfaction and medico-economic outcomes. ETHICS AND DISSEMINATION: The study was approved by the French national ethics committee (Comité de Protection des Personnes Est II, 5 December 2024, reference 24.04416.000295) and the institutional review board (IRB-COMERE, reference ICM-RCM 2024/11). The French National Agency for the Safety of Health Products has been notified. The study results will be presented at both national and international conferences and will also be published in a peer-reviewed journal. TRIAL REGISTRATION NUMBER: NCT06265558.

Indexed as

Breast NeoplasmsMastectomyNegative-Pressure Wound TherapyPostoperative ComplicationsSurgical Wound InfectionAdultClinical Trials, Phase III as TopicFemaleHumansMammaplastyMiddle AgedMulticenter Studies as TopicProspective StudiesQuality of LifeRandomized Controlled Trials as TopicWound HealingBreast surgeryClinical ProtocolsONCOLOGYWOUND MANAGEMENT

Identifiers

PMID41485781
PMCPMC12766763

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.